Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Nefopam hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nefopam 30mg tablets
0407010P0AAABAB
|
Nefopam hydrochloride | Nefopam hydrochloride | Central Nervous System | 72,731 |
|
Nefopam 60mg tablets
0407010P0AAAGAG
|
Nefopam hydrochloride | Nefopam hydrochloride | Central Nervous System | 542 |
|
Acupan 20mg/1ml solution for injection ampoules
0407010P0BBABAA
|
Acupan | Nefopam hydrochloride | Central Nervous System | No data available |
|
Acupan 30mg tablets
0407010P0BBAAAB
|
Acupan | Nefopam hydrochloride | Central Nervous System | No data available |
|
Nefopam 20mg/1ml solution for injection ampoules
0407010P0AAAAAA
|
Nefopam hydrochloride | Nefopam hydrochloride | Central Nervous System | No data available |
|
Nefopam 20mg/5ml oral suspension
0407010P0AAAEAE
|
Nefopam hydrochloride | Nefopam hydrochloride | Central Nervous System | No data available |
|
Nefopam 30mg/5ml oral suspension
0407010P0AAAFAF
|
Nefopam hydrochloride | Nefopam hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.